LGALS1 acts as the immune heterogeneity and immunosuppression in plenty of cancer, such as glioblastoma [34], clear cell renal carcinoma [35], non-small cell lung cancer [36]. This evidence concerns the gene LGALS1 and non-small cell lung carcinoma.